Tag: Covid 19 Drug

2 DG
Dr. Reddy's Laboratories Announces Commercial Launch Of Covid-19 Drug 2-DG

Dr. Reddy's Laboratories Ltd announced the commercial launch of 2-deoxy-D-glucose (2-DG).

  • Wednesday, 30 June 2021
Covifor
Hetero Gets DCGI Nod To Launch COVID-19 Drug 'Covifor'

New Delhi: Drug firm Hetero on Sunday said it has received approval from regulator DCGI to launch investigational antiviral drug Remdesivir for the treatment of COVID-19. Domestic pharma firm Glenmark Pharmaceuticals had on Saturday launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 at a […]

  • Thursday, 15 April 2021
Ramdev-Coronil
Row Over COVID Drug: FIR Against Yoga Guru Ramdev, 4 others

Jaipur: In another jolt to yoga guru Ramdev, an FIR has been lodged here against him, Patanjali Ayurved CEO Acharya Balkrishna and three others for allegedly making misleading claims that the herbal medicine company has found a cure for COVID-19 called Coronil. The complaint was filed at Jyoti Nagar police station in Jaipur on Friday. […]

  • Thursday, 15 April 2021
Favipiravir
Covid-19 Drug Favipiravir Price Drops To Rs 75/Tablet In India

New Delhi: Drug firm Glenmark Pharmaceuticals on Monday said it has cut price of its antiviral drug Favipiravir under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19, by 27 per cent to Rs 75 per tablet. Glenmark Pharmaceuticals had launched FabiFlu last month at a price of Rs 103 […]

  • Thursday, 15 April 2021
Fabiflu
Fighting COVID-19: Fabiflu More Economical & Effective Treatment Option, Claims Glenmark

New Delhi: In a strong rebuttal to the drug regulator, Glenmark Pharma said it has been at the receiving end of careless, unsubstantiated allegations that are devoid of merits related to Covid drug, Fabiflu. In a reply to V.G. Somani, Directorate General of Health Services, Central Drugs Standard Control Organisation, Glenmark has responded to allegations […]

  • Wednesday, 14 April 2021
remdesvir
COVID-19 Drug: Zydus Cadila Launches India's Cheapest Remdesivir Version

New Delhi: Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory […]

  • Tuesday, 13 April 2021
COVID19
COVID-19 Treatment: Preexisting Drug Shows Promise In Fight Against Coronavirus

New York: Using state-of-the-art computer simulations, the researchers have identified a preexisting drug that could fast-track a solution to this worldwide Covid-19 pandemic. For the study, published in the journal Science Advances, the research team from the University of Chicago in the US first focused on finding a weakness in the Covid-19 virus to target. […]

  • Tuesday, 13 April 2021
COVID-19-Drugs
Drug With Potential To Fight Covid-19 Identified

London: Scientists have identified a new drug that could prevent or mitigate the consequences derived from infection by SARS-CoV-2, the virus responsible for Covid-19. Preliminary results of the study conducted on animal models showed that the drug 4-Phenylbutiric acid (4-PBA) fully curbs mortality caused by respiratory failure derived from cellular stress, showed the research published […]

  • Monday, 12 April 2021
scrollToTop